ArticleJournal of neuroengineering and rehabilitation2026
Feasibility of the Meta Quest 3 for upper limb kinematic analysis: accuracy, consistency, agreement and reliability.
Article in Journal of neuroengineering and rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundUpper limb motor impairment is a frequent long-term consequence of a wide range of neurological and musculoskeletal conditions. Accurate assessment of motor function is essential to determine patient's condition and plan adequate interventions. While clinical scales are easy to administer and not time-consuming, they could have limited accuracy and be biased. Kinematic analysis can provide detailed, quantitative information but usually depends on expensive, complex, and non-portable systems. Recent virtual reality head-mounted displays, with integrated hand-tracking, offer a promising, low-cost, and portable alternative to conduct upper limb kinematic assessment. However, the accuracy, consistency, agreement and reliability of kinematic variables derived from the hand tracking feature of these devices, as well as the impact of signal preprocessing on feature extraction, remain largely unexplored.
methodsThirty-nine healthy subjects performed five upper-limb tasks including tracking, point-reaching, and reach-and-grasp, while their movements were simultaneously recorded using a laboratory-grade motion capture system and the Meta Quest 3 headset. Multiple kinematic variables were extracted from the hand trajectories of both systems and analysed to evaluate accuracy, consistency, agreement and reliability. Additionally, the impact of signal smoothing on the extracted kinematic values was examined.
resultsMinimal absolute and relative errors were estimated between systems, showing high concordance and consistency across most kinematic variables and tasks. Importantly, the differences observed remained below the minimal detectable change of the motion capture system. Test-retest reliability of kinematic measures estimated by the Meta Quest 3 was moderate to good for nearly all variables with the only exception of the number of movement units, which consistently showed poor reliability across all tasks, indicating limited robustness of this metric. The signal smoothing was found to influence the magnitude of the estimated errors, highlighting the importance of optimizing the preprocessing to maximize the accuracy of the Meta Quest 3.
conclusionsOur findings support the feasibility of using the Meta Quest 3 as a cost-effective and portable alternative to laboratory-grade motion capture systems for kinematic evaluation of upper-limb motor function. However, caution is warranted regarding the selection of variables and tasks, particularly for metrics with limited robustness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.